[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-367784-105":59,"doc-detail-367784-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","deep-exploration-of-the-immunopeptidome-of-a-pancreatic-cancer-cell-line-implications-for-clinical-immunopeptidomics-and-immunotherapy","Deep Exploration of the Immunopeptidome of a Pancreatic Cancer Cell Line: Implications for Clinical Immunopeptidomics and Immunotherapy","","Study applies a robust SCIEX ZenoTOF 7600 workflow to identify HLA-bound peptides from the Panc1 pancreatic cancer cell line using offline fractionation to achieve deep immunopeptidome coverage. The work compares DDA and DIA strategies for very small cellular inputs (~1 mg or ~1 million cells) to support clinical biopsy compatibility. High-pH RP fractionation improves confidence in HLA peptide identification and enables detection of clinically relevant CTA-derived immunopeptides even at low inputs. The study discusses how optimized DDA or ZenoSWATH-DIA can underpin future translational immunopeptidomics for tumor antigen presentation screening in minimal samples.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/deep-exploration-of-the-immunopeptidome-of-a-pancreatic-cancer-cell-line-implications-for-clinical-immunopeptidomics-and-immunotherapy/367784/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/deep-exploration-of-the-immunopeptidome-of-a-pancreatic-cancer-cell-line-implications-for-clinical-immunopeptidomics-and-immunotherapy/367784.png","ImageObject",300,407,{"name":92,"@type":93},"Mimi","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-05","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",17,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What workflow was used to identify HLA-bound peptides from the Panc1 cell line?","Question",{"text":113,"@type":114},"The study used an offline fractionation strategy combined with SCIEX ZenoTOF 7600 data acquisition to identify HLA-bound peptides from Panc1 cells.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How do the results compare between DDA and DIA approaches for small cellular inputs?",{"text":118,"@type":114},"The study compares DDA and DIA-based strategies and shows that both can enable robust detection of CTA-derived and potentially clinically actionable immunopeptides at inputs as low as ~1 million cells.",{"name":120,"@type":111,"acceptedAnswer":121},"Why is high-pH RP offline fractionation important in this immunopeptidomics strategy?",{"text":122,"@type":114},"High-pH RP fractionation increased confidence in HLA peptide identification, especially when dealing with cofragmenting precursors in DIA workflows.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},367784,1790218737,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":146,"preview_page_count":19,"preview_urls":147},2336477974920,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","Deep Exploration of the Immunopeptidome of a Pancreatic Cancer Cell Line: Implications for Clinical Immunopeptidomics and Immunotherapy  \nAuthors  \nMohammadreza Dorvash, Patricia T. Illing, Nathan P. Croft, Sri H. Ramarathinam, and Anthony W. Purcell  \nCorrespondence  \n[anthony.purcell@monash.edu](anthony.purcell@monash.edu)  \nIn Brief  \nIn this study, we have applied a robust and sensitive workflow utilising the SCIEX ZenoTOF 7600 to identify the HLA bound peptides from the Panc1 cell line using an offline fractionation strategy to obtain very deep coverage of the immunopeptidome. We compare DDA and DIA-based approaches for the study of small cellular inputs (~1 mg or 1 million cells) making them applicable to clinical biopsy studies.  \nGraphical Abstract  \nHighlights  \n• High-pH RP offline fractionation increased confidence in HLA peptide identification.  \n• Clinically relevant HLA-bound peptides were identified from low-input material.  \n• The benefits of using an optimized DDA or ZenoSWATH-DIA approaches are discussed.  \n2025, Mol Cell Proteomics 24(8), 101030  \n© 2025 THE AUTHORS. Published by Elsevier Inc on behalf of American Society for Biochemistry and Molecular Biology. This is an open access article under the CC BY-NC-ND license ([http://](http://)[ ](http://)[creativecommons.org/licenses/by-nc-nd/4.0/](creativecommons.org/licenses/by-nc-nd/4.0/)).  \n[https://doi.org/10.1016/j.mcpro.2025.101030](https://doi.org/10.1016/j.mcpro.2025.101030)  \n RESEARCH  \n| Deep Exploration of the Immunopeptidome of a Pancreatic Cancer Cell Line: Implications for Clinical Immunopeptidomics and Immunotherapy\u003Cbr>Mohammadreza Dorvash , Patricia T. Illing , Nathan P. Croft , Sri H. Ramarathinam,\u003Cbr>and Anthony W. Purcell* |  |\n| --- | --- |\n| Pancreatic ductal adenocarcinoma (PDAC), with its devastating prognosis and limited treatment options, demands innovative therapeutic strategies. T-cell-based immunotherapy has shown promise for many cancers, including PDAC, but is limited by our knowledge of the breadth of cancer-specific T-cell epitopes available. Thus, a comprehensive assessment of the immunopeptidome of PDAC is essential to pave the way for the effective design of immunotherapy and related interventions. In this study, we immunoaffinity purified Human Leukocyte Antigen (HLA) class I-bound peptides from the Panc1 cell line grown in the absence and presence of cytokine stimulation. These peptides were subjected to an off-line high-pH reversed-phase (HPH-RP) fractionation prior to data acquisition. We demonstrate that HPH-RP fractionation followed by data-dependent acquisition (DDA) is a relatively simple and reliable technique that expands the depth of coverage of the PDAC immunopeptidome, allowing the identification of over 22,500 canonical HLA-bound peptides. In addition, the complementary separation by HPH-RP improved the identification confidence, particularly in the case of cofragmenting precursors in data-independent acquisition (DIA) workflows. This strategy facilitated the identification of a high number of cancer-testis antigen (CTA)-derived immunopeptides. However, given that fractionation is typically associated with an adsorptive loss, it is impractical to apply HPH-RP on often minuscule clinical specimens and biopsies. Thus, we explored the feasibility of immunopeptidome analysis with cellular inputs as low as 1 million cells (equivalent to approximately 1 mg of tissue) using either a ZenoSWATH DIA interpreted using a spectral library derived from the HPH-RP strategy, or an optimized DDA workflow on the SCIEX ZenoToF 7600 system. Both approaches enabled robust detection of CTA-derived and other potentially clinically actionable immunopeptides even at the lowest cellular inputs. We | discuss the relative merits of both acquisition strategies and how they can form the basis for future clinical translational immunopeptidomics approaches to screen tumor antigen presentation in low cellular input PDAC biopsies and provide n","cbCaidY5uTTSn1Gt","https://ap.wps.com/l/cbCaidY5uTTSn1Gt","pdf",5643366,15,"English","# Study overview\n## Workflow and instrumentation\n## Comparison of DDA and DIA\n## Low-input clinical feasibility","[{\"question\":\"What workflow was used to identify HLA-bound peptides from the Panc1 cell line?\",\"answer\":\"The study used an offline fractionation strategy combined with SCIEX ZenoTOF 7600 data acquisition to identify HLA-bound peptides from Panc1 cells.\"},{\"question\":\"How do the results compare between DDA and DIA approaches for small cellular inputs?\",\"answer\":\"The study compares DDA and DIA-based strategies and shows that both can enable robust detection of CTA-derived and potentially clinically actionable immunopeptides at inputs as low as ~1 million cells.\"},{\"question\":\"Why is high-pH RP offline fractionation important in this immunopeptidomics strategy?\",\"answer\":\"High-pH RP fractionation increased confidence in HLA peptide identification, especially when dealing with cofragmenting precursors in DIA workflows.\"}]","Deep Exploration of the Immunopeptidome of a Pancreatic Cancer Cell Line: Implications for Clinical Immunopeptidomics and Immunotherapy | PDF",1790172601,38,[148,152,156,160],{"page_no":8,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0c1ab6645373a626a8c60d5afd46ce64.webp",983,1296,{"page_no":14,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/331e9077f207dd7192f03648814ac306.webp",982,1294,{"page_no":81,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1d02c6595e284a017670254b256c0b67.webp",981,1293,{"page_no":19,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b0d2d364bb0586bbf4fc9efaa0950706.webp",980,1292]